Immunome Income Statement (2019-2026) | IMNM

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
2.36M4.26M3.56M3.83M1.03M2.36M2.91M2.74M2.93M4.01M
Operating items
Research & Development (Quarter)
3.23M4.51M4.38M8.08M5.72M5.22M4.25M3.91M5.72M3.82M9.64M15.37M29.08M37.20M47.89M36.87M40.45M49.19M50.77M46.38M
Selling, General & Administrative (Quarter)
2.51M3.21M3.46M3.58M3.21M3.31M3.54M2.92M4.32M4.38M8.04M6.00M6.98M9.53M10.45M10.69M10.04M10.95M12.09M12.95M
Other Operating Expenses (Quarter)
80.80M111.95M6.31M6.71M27.37M10.00M
Operating Expenses (Quarter)
5.74M7.72M7.84M11.65M8.93M8.53M7.79M6.83M10.04M8.20M98.48M133.33M42.37M53.43M85.71M47.56M50.49M60.14M72.86M59.33M
Operating Income (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
EBIT (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
Non-operating items
Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
Profit After Tax (Quarter)
-5.24M-7.72M-7.85M-11.70M-8.92M-8.53M-7.79M-4.27M-5.56M-4.34M-92.63M-129.49M-36.12M-47.10M-80.25M-41.64M-43.40M-57.46M-69.90M-53.84M
Income from Continuing Operations (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
Consolidated Net Income (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
Income towards Parent Company (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
Preferred Dividend Payments (Quarter)
0.62M
Net Income towards Common Stockholders (Quarter)
-5.74M-7.72M-7.85M-11.65M-8.93M-9.15M-7.79M-4.47M-5.77M-4.34M-92.63M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M
Additional items
EPS (Basic) (Quarter)
-0.46-0.65-0.65-0.96-0.74-0.75-0.64-0.35-0.46-0.36-4.22-2.51-0.60-0.78-1.28-0.52-0.50-0.65-0.75-0.48
EPS (Weighted Average and Diluted) (Quarter)
-0.46-0.65-0.65-0.96-0.74-0.75-0.64-0.35-0.46-0.36-4.22-2.51-0.60-0.78-1.28-0.52-0.50-0.65-0.75-0.48
Shares Outstanding (Weighted Average) (Quarter)
0.86M0.50M11.54M12.12M0.50M0.50M12.13M0.80M0.50M0.50M19.84M0.16M59.94M57.24M58.64M79.41M87.01M87.96M87.35M113.14M
Shares Outstanding (Diluted Average) (Quarter)
11.46M11.35M11.54M12.12M12.13M12.13M12.13M12.18M12.19M12.20M19.84M51.54M59.94M57.24M58.64M79.41M83.23M87.96M87.35M113.14M
EBITDA (Quarter)
-5.74M-7.72M-7.84M-11.65M-8.93M-8.53M-7.79M-4.47M-5.77M-4.63M-94.65M-132.30M-40.01M-50.52M-82.97M-44.64M-46.48M-60.14M-72.86M-59.33M